SOURCE: Ikonisys, Inc.

December 16, 2008 08:01 ET

Ikonisys to Present at the J.P. Morgan 27th Annual Healthcare Conference

NEW HAVEN, CT--(Marketwire - December 16, 2008) - Ikonisys, a leading provider of next-generation, cell-based diagnostic solutions, announced today that Dr. Petros Tsipouras, Chairman and Chief Executive Officer, will present at the J.P. Morgan 27th Annual Healthcare Conference on Thursday, January 15, 2009, at 9:00 a.m. Pacific Time. The conference is being held at the Westin St. Francis Hotel in San Francisco, CA.

About Ikonisys

Founded in 1999, Ikonisys, Inc. is a privately-held, next generation diagnostic company specializing in non-invasive, cell-based diagnostics. Ikonisys has developed the CellOptics® platform, a robotic microscopy technology for fully-automated, high-throughput identification and analysis of rare cells by fluorescent in-situ hybridization (FISH). A pipeline of applications are being developed for cancer diagnosis and management (oncoFISH®) and prenatal detection of genetic disorders (fastFISH®) to be run on the Ikoniscope® using the CellOptics technology. Ikonisys' first proprietary test, oncoFISH cervical, is offered as a Laboratory Developed Test through the Company's CAP-accredited clinical laboratory. In addition to oncoFISH cervical, the Company offers three FDA-cleared applications that automate certain commercially available FISH tests.

To learn more visit www.ikonisys.com.

Contact Information

  • Media Contact:
    Alex Salvi
    Renee Viola
    Ikonisys
    203-776-0791
    Email Contact

    Investor Relations Contact:
    Louise Mawhinney
    Ikonisys
    203-776-0791
    Email Contact